Trial · NCT03888755
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Onset of Symptom Relief (TOSR) | Icatibant | 1.75 | 95% Confidence Interval 1.00 to 2.50 | Hours | |
| Time to Onset of Primary Symptom Relief (TOSR-P) | Icatibant | 1.07 | 95% Confidence Interval 1.00 to 2.00 | Hours | |
| Change From Baseline in the Composite Visual Analog Scale (VAS) Score | Icatibant | Baseline | 30.78 | Standard Deviation 13.465 | Score on a scale |
| Change From Baseline in the Composite Visual Analog Scale (VAS) Score | Icatibant | 2 hours | -19.26 | Standard Deviation 13.310 | Score on a scale |
| Change From Baseline in the Composite Visual Analog Scale (VAS) Score | Icatibant | 4 hours | -24.57 | Standard Deviation 13.367 | Score on a scale |
| Change From Baseline in the Composite Visual Analog Scale (VAS) Score | Icatibant | 8 hours | -29.40 | Standard Deviation 12.998 | Score on a scale |
| Composite Symptom Score (SS) Assessed by Investigator | Icatibant | 0.12 | Standard Deviation 0.18 | Score on a scale | |
| Composite Symptom Score (SS) Assessed by Participant | Icatibant | 0.14 | Standard Deviation 0.16 | Score on a scale | |
| Investigator Global Assessment | Icatibant | Cutaneous Symptoms: 2 hours (h) post dose | 0.9 | Standard Deviation 0.99 | Score on a scale |
| Investigator Global Assessment | Icatibant | Cutaneous Symptoms: 4 h post dose | 0.6 | Standard Deviation 0.52 | Score on a scale |
| Investigator Global Assessment | Icatibant | Cutaneous Symptoms: 8 h post dose | 0.5 | Standard Deviation 0.53 | Score on a scale |
| Investigator Global Assessment | Icatibant | Abdominal Symptoms: 2 h post dose | 0.1 | Standard Deviation 0.35 | Score on a scale |
| Investigator Global Assessment | Icatibant | Abdominal Symptoms: 4 h post dose | 0.0 | Standard Deviation 0.00 | Score on a scale |
| Investigator Global Assessment | Icatibant | Abdominal Symptoms: 8 h post dose | 0.0 | Standard Deviation 0.00 | Score on a scale |
| Investigator Global Assessment | Icatibant | Laryngeal Symptoms: 2 h post dose | 0.0 | Standard Deviation 0.00 | Score on a scale |
| Investigator Global Assessment | Icatibant | Laryngeal Symptoms: 4 h post dose | 0.0 | Standard Deviation 0.00 | Score on a scale |
| Investigator Global Assessment | Icatibant | Laryngeal Symptoms: 8 h post dose | 0.0 | Standard Deviation 0.00 | Score on a scale |
| Time to Initial Symptom Improvement by Investigator | Icatibant | 0.98 | 95% Confidence Interval 0.30 to 2.00 | H | |
| Time to Initial Symptom Improvement by Participants | Icatibant | 1.04 | 95% Confidence Interval 0.30 to 2.05 | h | |
| Time to Almost Complete Symptom Relief As Assessed by Visual Analog Scale (VAS) Score | Icatibant | 5.98 | Inter-Quartile Range 2.27 to 8.00 | H |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03888755/results